Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Following Chemoradiation in Locally Advanced NSCLC
NCT00417248Phase 2Terminated
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC). Started Jun 2007; status: terminated.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00417248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417248.